Cite
HARVARD Citation
Young, G. et al. (2023). Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial. Lancet. 401 (10386), pp. 1427-1437. [Online].